<DOC>
	<DOCNO>NCT00401583</DOCNO>
	<brief_summary>This Phase I study determine effect GW786034 ( pazopanib ) P450 enzymes . This study help determine type drug may interact GW786034 .</brief_summary>
	<brief_title>A Study To Test The Effect Of GW786034 ( Pazopanib ) On P450 Enzymes</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<criteria>Inclusion criterion : Histologically cytologically confirm diagnosis advance solid tumor . Eastern Cooperative Oncology Group ( ECOG ) performance status 0 1 . Adequate bone marrow , renal , lung , liver function . A female subject must pregnant agree become pregnant trial Exclusion criterion : Any major surgery , chemotherapy , hormone therapy , investigational drug , radiotherapy within last 28 day . Poorly control hypertension . Corrected QT ( QTc ) prolongation define QTc interval great equal 480 msec prior history cardiovascular disease , arrhythmia , significant ECG abnormality . Arterial venous thrombus ( include cerebrovascular accident ) , myocardial infarction , admission unstable angina , cardiac angioplasty , stenting within last 3 month . Current use therapeutic anticoagulation ( low molecular weight heparin , oral anticoagulant agent ) . Amiodarone must take least 6 month prior administration first dose study drug . History brain metastasis . Has narrowangle glaucoma contraindication midazolam use . History nicotinecontaining product ( include cigarette , cigar , nicotine patch ) use within past 6 month . A history bleeding problem .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>GW786034 ( pazopanib ) cytochrome P450 interaction</keyword>
</DOC>